Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF
Here is the latest financial fact sheet of INDRAPRASTHA MEDICAL. For more details, see the INDRAPRASTHA MEDICAL quarterly results and INDRAPRASTHA MEDICAL share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -1.3 |
No. of shares | m | 91.67 |
1 Week | % | -1.4 |
1 Month | % | 39.9 |
1 Year | % | 180.1 |
52 week H/L | Rs | 255.0/80.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
INDRAPRASTHA MEDICAL EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 52 | 52 | 70 | 103 | 94 | |
Low | Rs | 36 | 27 | 31 | 54 | 52 | |
Sales per share (Unadj.) | Rs | 86.0 | 90.6 | 66.9 | 96.9 | 119.9 | |
Earnings per share (Unadj.) | Rs | 3.1 | 4.8 | 0.3 | 6.4 | 9.4 | |
Diluted earnings per share | Rs | 3.1 | 4.8 | 0.3 | 6.4 | 9.4 | |
Cash flow per share (Unadj.) | Rs | 6.3 | 8.4 | 3.9 | 10.2 | 13.7 | |
Dividends per share (Unadj.) | Rs | 1.60 | 0 | 0 | 2.50 | 3.00 | |
Adj. dividends per share | Rs | 1.60 | 0.00 | 0.00 | 2.50 | 3.00 | |
Avg Dividend yield | % | 3.6 | 0 | 0 | 3.2 | 4.1 | |
Book value per share (Unadj.) | Rs | 26.6 | 29.2 | 29.8 | 35.5 | 41.4 | |
Adj. book value per share | Rs | 26.6 | 29.2 | 29.8 | 35.5 | 41.4 | |
Shares outstanding (eoy) | m | 91.67 | 91.67 | 91.67 | 91.67 | 91.67 | |
Price / Sales ratio | x | 0.5 | 0.4 | 0.8 | 0.8 | 0.6 | |
Avg P/E ratio | x | 14.2 | 8.4 | 199.1 | 12.2 | 7.8 | |
P/CF ratio (eoy) | x | 6.9 | 4.8 | 13.0 | 7.7 | 5.3 | |
Price / Book Value ratio | x | 1.7 | 1.4 | 1.7 | 2.2 | 1.8 | |
Dividend payout | % | 51.6 | 0 | 0 | 39.1 | 31.9 | |
Avg Mkt Cap | Rs m | 4,040 | 3,660 | 4,639 | 7,176 | 6,694 | |
Total wages/salary | Rs m | 2,002 | 2,139 | 1,977 | 2,139 | 2,467 |
INDRAPRASTHA MEDICAL INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 7,882 | 8,308 | 6,134 | 8,882 | 10,987 | |
Other income | Rs m | 5 | 7 | 7 | 31 | 100 | |
Total revenues | Rs m | 7,886 | 8,315 | 6,141 | 8,913 | 11,087 | |
Gross profit | Rs m | 808 | 864 | 403 | 1,143 | 1,507 | |
Depreciation | Rs m | 298 | 330 | 333 | 349 | 393 | |
Interest | Rs m | 69 | 59 | 33 | 34 | 43 | |
Profit before tax | Rs m | 446 | 482 | 43 | 791 | 1,172 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 162 | 46 | 20 | 205 | 310 | |
Profit after tax | Rs m | 284 | 436 | 23 | 586 | 862 | |
Gross profit margin | % | 10.2 | 10.4 | 6.6 | 12.9 | 13.7 | |
Effective tax rate | % | 36.3 | 9.5 | 45.7 | 25.9 | 26.5 | |
Net profit margin | % | 3.6 | 5.3 | 0.4 | 6.6 | 7.8 |
INDRAPRASTHA MEDICAL BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 1,356 | 1,415 | 1,414 | 1,574 | 2,231 | |
Current liabilities | Rs m | 1,241 | 1,396 | 1,159 | 935 | 1,296 | |
Net working cap to sales | % | 1.5 | 0.2 | 4.2 | 7.2 | 8.5 | |
Current ratio | x | 1.1 | 1.0 | 1.2 | 1.7 | 1.7 | |
Inventory Days | Days | 3 | 2 | 2 | 11 | 18 | |
Debtors Days | Days | 35 | 35 | 4 | 2 | 2 | |
Net fixed assets | Rs m | 2,868 | 3,075 | 2,905 | 3,043 | 3,321 | |
Share capital | Rs m | 917 | 917 | 917 | 917 | 917 | |
"Free" reserves | Rs m | 1,524 | 1,761 | 1,811 | 2,338 | 2,878 | |
Net worth | Rs m | 2,440 | 2,678 | 2,728 | 3,254 | 3,795 | |
Long term debt | Rs m | 150 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 4,224 | 4,490 | 4,320 | 4,617 | 5,551 | |
Interest coverage | x | 7.5 | 9.1 | 2.3 | 24.2 | 28.4 | |
Debt to equity ratio | x | 0.1 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 1.9 | 1.9 | 1.4 | 1.9 | 2.0 | |
Return on assets | % | 8.4 | 11.0 | 1.3 | 13.4 | 16.3 | |
Return on equity | % | 11.6 | 16.3 | 0.9 | 18.0 | 22.7 | |
Return on capital | % | 19.9 | 20.2 | 2.8 | 25.3 | 32.0 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 1,483 | 1,408 | 620 | 1,042 | 1,905 | |
Fx outflow | Rs m | 149 | 344 | 52 | 183 | 360 | |
Net fx | Rs m | 1,334 | 1,064 | 568 | 859 | 1,545 |
INDRAPRASTHA MEDICAL CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 752 | 865 | 268 | 943 | 1,445 | |
From Investments | Rs m | -167 | -402 | -191 | -741 | -1,079 | |
From Financial Activity | Rs m | -442 | -427 | -31 | -34 | -260 | |
Net Cashflow | Rs m | 143 | 35 | 46 | 168 | 105 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Jasmine Shah | COMP SEC: Priya Ranjan | YEAR OF INC: 1988 | BSE CODE: 532150 | FV (Rs): 10 | DIV YIELD (%): 1.3 |
Read: INDRAPRASTHA MEDICAL 2022-23 Annual Report Analysis
More Hospital & Healthcare Services Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare INDRAPRASTHA MEDICAL With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Asian markets traded lower on Friday tracking overnight losses on Wall Street and inflation data from Japan.